In moderately diabetic rats (plasma glucose 20-30 mmol/L), where there is some residual pancreatic islet function, normoglycemia can be restored by transplantation of pancreatic islets into the liver via the portal vein. To examine whether normoglycemia can also be achieved in more severely diabetic animals (which more closely resemble human type I diabetes), we have compared the effect of transplanting 1000 islets intraportally in Lewis rats made moderately diabetic (55 mg/kg streptozotocin injected IP while nonfasting) or severely diabetic (65 mg/kg streptozotocin injected IP while fasting). In the moderately diabetic rats in which residual pancreatic insulin was 128 ± 40 mU insulin (2.0% of control), plasma glucose stabilized (32 ± 2.8 mmol/L at 1 week, 34 ± 2 mmol/L at 3 weeks) as did body weight (falling from 290 ± 5 to 265 ± 5 g at 1 week and 253 ± 6 g at 3 weeks). In contrast, in severely diabetic rats in which residual pancreatic insulin was only 13.5 ± 4.2 mU insulin (0.21% of control), there was a progressive rise in plasma glucose (30 ± 1.3 mmol/L at 1 week, 49 ± 4 mmol/L at 2 weeks, and 67 ± 7 mmol/L at 3 weeks) and a progressive fall in body weight (from 304 ± 10 to 260 ± 5 g by week 1 and to 209 ± 6 g by week 3). Following islet transplantation, nonfasting plasma glucose normalized in moderately diabetic rats (10.5 ± 0.6 vs. 9.1 ± 0.6 mmol/L in nondiabetic controls, NS) after 23 ± 5 days. In contrast, in the severely diabetic rats plasma glucose stabilized at 32 ± 5mmol/L (p < 0.05 compared to moderately diabetic group) but did not normalize. This difference was not attributable to different plasma glucose levels at the time of transplantation (35.1 ± 1.8 in moderately diabetic vs. 32.5 ± 2.5 mmol/L in severely diabetic rats). These observations demonstrate that residual native β-cells (equivalent to only 60-80 islets) contribute to the survival or function of intraportally transplanted islets.
INTRODUCTION
plasma glucose levels of 20-30 mmol/L, and it is unclear whether normoglycemia can be as easily achieved in animals whose insulin deficiency more closely resem-Intraportal transplantation of pancreatic islets leads to long-term correction of type I diabetes in less than 10% bles type I diabetes. In animals with more complete insulin deficiency, much larger numbers of islets (5000) of patients, despite the fact that survival of transplanted islets, as evidenced by circulating C peptide levels, can are necessary to correct the diabetes (21), but these studies used fetal islets, which respond poorly to glucose be demonstrated in over 50% of patients (10). The number of islets transplanted is known to be a major deter- (12, 24) . To examine whether the outcome of intrahepatic islet minant of the outcome of islet transplantation, and it seems likely that the disappointing insulin independence transplantation is influenced by the severity of the underlying diabetes, we compared intraportal islet trans-rates reflect the fact that insufficient numbers of islets survive the transplantation procedure (11). In diabetic plantation in moderately diabetic rats in which 98% of the pancreatic β-cells had been destroyed by streptozo-rats, the minimum number of islets required to normalize blood glucose by intraportal injection has been re-tocin and severely diabetic rats in which 99.8% of the β-cells had been destroyed. We sought to establish pre-ported to be 600-1000 islets, equivalent to 12.5-25% of the endocrine volume of control animals (16, 17, 28, 29) .
cisely the minimum number of islets required to normalize plasma glucose in the moderately diabetic group and However, these studies have been carried out in animals that have some residual β-cell function and stable examined the effect of the same graft size in the severely 146 HUGHES, POWIS, AND PRESS diabetic animals. We transplanted the animals at a time (2) using rat insulin as standard. The insulin content of plasma derived from portal vein and peripheral blood when plasma glucose levels were the same in the two groups to avoid any differential effects of glucose tox-was determined by RIA, and an aliquot from each islet preparation was also extracted by sonication and subse-icity.
quently assayed for insulin content.
MATERIALS AND METHODS

Statistical Analysis Animals and Induction of Diabetes
Results are given as means ± SEM for the number of Inbred male Lewis rats (280-300 g) supplied by Harexperiments indicated. Statistical analysis was carried lan Olac (Bicester, Oxfordshire, UK) were used as both out using Student's t-test. donors and recipients for islet transplants. Diabetes was induced by streptozotocin (Sigma Chemicals, Poole, RESULTS Dorset, UK) injected (IP) into fed rats (at 55 mg/kg) or Diabetes Induction into overnight-fasted rats (at 65 mg/kg). The streptozo-Injection of 55 mg/kg streptozotocin into fed rats intocin solution was prepared fresh and was used immediduced diabetes within 1 week such that plasma glucose ately. Hyperglycemia was confirmed in diabetic animals stabilized at 32 ± 2.8 mmol/L and was 34 ± 2.0 mmol/L by plasma glucose determination 1-2 days prior to at 3 weeks ( Fig. 1 ). Body weight fell from 290 ± 5 g to transplantation.
265 ± 5 g after 1 week and to 253 ± 6 g at 3 weeks.
Islet Isolation and Transplantation
These animals with stable diabetes are referred to as Islets of Langerhans were isolated from the pancreata "moderately diabetic." Spontaneous recovery and norof nondiabetic animals by collagenase digestion followmalization of plasma glucose was not observed in any ing injection of 3.0 ml collagenase solution (collagenase animals (n = 6) monitored up to 8 weeks after diabetes P, Boehringer Mannheim, Lewes, East Sussex, UK) at induction. In contrast, following injection of 65 mg/kg 1.5 mg/ml in HEPES-buffered Hanks balanced salts sostreptozotocin into fasted rats, there was a progressive lution (HBSS) into the pancreatic duct (27) . Islets in the rise in plasma glucose (30 ± 1.3 mmol/L at 1 week, 49 pancreatic digest were then purified by centrifugation on ± 4 mmol/L at 2 weeks, and 67 ± 7 mmol/L at 3 weeks) a bottom loaded discontinuous dextran gradient (4, 15) , and a progressive fall in body weight (from 304 ± 10 to collected, and counted using a 20-µl pipette in HBSS 260 ± 5 g by week 1 and to 209 ± 6 g by week 3). These containing 0.5% BSA under a dissecting microscope.
animals with progressive diabetes are described as "se-Before transplantation, the islets were washed three verely diabetic." Mortality in this group of diabetic rats times in filter-sterilized HBSS containing 10% (v/v) rat was 14%. serum. Following laparotomy under halothane anesthe-Islet Transplants in Moderately Diabetic Rats sia, islets were injected into the portal vein in 0.3 ml of the same medium through a 25-gauge needle. The sy-Increasing the number of islets transplanted progressively improved nonfasting plasma glucose levels and ringe was held in place and the chamber rinsed with 0.3 ml portal blood. After withdrawal of the needle, the weight gain in moderately diabetic recipients ( Fig. 2A,  B ). Graft sizes of 500 and 700 islets reduced the plasma injection site was clamped by hand for 1 min to minimize blood loss. The syringe and needle were washed glucose by approximately 8 mmol/L (to approx. 25 mmol/1) and stabilized the body weight of the animals. out with HEPES-buffered HBSS containing 0.5% BSA and this medium was examined to count the number of In contrast, 1000 islets normalized nonfasting plasma glucose (10.5 ± 0.6 mmol/L compared to 9.1 ± 0.6 mmol/L noninjected islets.
Plasma glucose concentrations were determined by in controls, NS) by 5 weeks after transplantation and normalized weight gain. A graft size of 1500 islets nor-the glucose oxidase method on a Cobas Mira autoanalyzer (Roche, Welwyn Garden City, Herts., UK). Blood malized plasma glucose by 2 weeks. In Figure 2C these data are presented as a dose-response curve at 6 weeks samples were collected from the amputated tail tips of anesthetized rats. Plasma was collected after centrifuga-after transplantation when nonfasting plasma glucose concentrations had stabilized. A half-maximal effect was tion and stored at −20°C until analysis. Some animals underwent an intraperitoneal (2 mg/g body weight) glu-observed at a graft size of approximately 750 islets and normalization of glycemia at 1000 islets. Glucose toler-cose tolerance test after an overnight fast as described previously (13).
ance was assessed in transplanted rats that became normoglycemic, including two animals that received grafts Insulin was extracted postmortem from the homogenized pancreata of diabetic animals, controls, or trans-of 850 islets (Fig. 3 ). Glucose tolerance clearly improved with increasing graft size. However, in all trans-plant recipients using 0.18 M hydrochloric acid in ethanol (70%, v/v) for 24 h at 4°C and quantified by RIA plant recipients glucose tolerance was impaired, even in those animals that received the largest graft (1500 islets), although in this group plasma glucose was not significantly different to controls at the 2-h time point. levels (compare with Fig. 1 ). The body weights of the animals did not increase, as in the case of moderately diabetic rats transplanted with 1000 islets, although they did stabilize (Fig. 4B ). The plasma glucose levels immediately prior to transplantation were similar in the two groups of animals (35.1 ± 1.8 in moderately diabetic vs. 32.5 ± 2.5 mmol/L in severely diabetic rats, NS) as was the insulin content of the islets transplanted into the moderately and severely diabetic rats (1.98 ± 0.14 and 1.99 ± 0.16 mU/islet, respectively).
Portal Vein and Pancreatic Insulin Content in Moderately and Severely Diabetic Rats
At the time of transplantation (7 days after diabetes induction), the insulin content of blood collected from the portal vein of moderately diabetic rats was fivefold higher than that of severely diabetic animals (p < 0.05, Table 1 ) but significantly lower than that of controls. The insulin content of peripheral blood was also signifirats. Diabetes was induced by streptozotocin injection (IP) into cantly higher in the moderately diabetic compared to the fed rats at 55 mg/kg body weight (G) or fasted rats at 65 mg/ severely diabetic animals, where it was barely detectkg (᭺) and 1000 islets transplanted intraportally approxiable. In all groups, the insulin content of blood collected mately 1 week later. Data show the mean ± SEM of 4 or 5 from the portal vein was higher than that of peripheral observations. *p < 0.05, Student's t-test.
blood. Residual pancreatic insulin extracted postmortem in moderately diabetic rats was 2.0% of controls (which was 6.3 ± 0.4 U per pancreas) and was significantly higher than in severely diabetic animals (0.21% of controls). When extracted at 6 weeks after transplantation, insulin content in pancreata from moderately and se-The observation that a graft size of 1000 islets, which verely diabetic rats had not changed (Table 1) .
was sufficient to normalize plasma glucose in moderately diabetic animals, failed to do so in the severely diabetic rats suggests that residual β-cell function in the DISCUSSION moderately diabetic animals either contributes to the sur-In the present study we have produced two models vival of the intraportally transplanted islets or contribof diabetes in rats that we designate as moderate and utes directly to diabetic control. Based on the extractable severe diabetes. In the moderately diabetic animals insulin content of the native pancreata, we estimate that whose pancreata retained 2% of control insulin content the number of surviving islets in the moderately diabetic on postmortem analysis, plasma glucose concentrations group was ϳ80, whereas it was <10 in the severely diarose and body weights fell during the first week but both betic group (compared to >3000 in a normal pancreas). then stabilized. On the basis of the stable plasma glucose Hyperglycemia develops following 90% pancreatectomy levels, this model is similar to many used in islet transin rats (3), indicating that 10% of the normal β-cell mass plantation studies (6, 8, 16, 17, 28, 29) . In contrast, in the is insufficient to maintain normal glucose homeostasis. severely diabetic animals that retained only 0.2% of con-We would thus expect the insulin output of only 2% of trol pancreatic insulin, plasma glucose increased prothe normal β-cell mass to exert a negligible metabolic gressively, reaching 60 mmol/L and body weight deeffect. Furthermore, if the difference between the modclined progressively. The dose of streptozotocin we used erate and severely diabetic animals were due to metain this group (65 mg/kg) was not much larger than that bolic effects of the residual native β-cells, we would which we and others used to induce moderate diabetes have expected the estimated 10-fold difference in the (6, 16, 28) , and it is possible that the severity of the metanumber of surviving β-cells to have resulted in different bolic disturbance resulted from the fact that the fasting glucose concentrations at the time of transplantation. of the animals increased the uptake of streptozotocin It has been shown that hyperglycemia impairs the into pancreatic β-cells via GLUT 2 transporters (26).
function and possibly the implantation of islets in dia-The graft size that successfully and consistently norbetic animals. Hyperglycemia has both short-and longmalized plasma glucose in our model of moderate diabeterm effects, impairing the vascularization of islet grafts tes (1000 islets) is comparable to the number of islets or in diabetic rats (25) as well as acutely reducing the insuendocrine volume that has been found to normalize lin content (6,20) and chronically reducing the β-cell plasma glucose in other studies (28, 29) . The observation mass of small islet grafts placed under the kidney capthat the smaller graft sizes that normalized nonfasting sule of diabetic mice (7). However, the transplanted isplasma glucose did not normalize glucose tolerance also lets in the severely diabetic rats in the present study confirms previous findings (17, 29) . Our observation that were not subject to more extreme hyperglycemia at the increasing the graft size improved glucose tolerance time of transplantation. Indeed, the plasma glucose conmight suggest that normal glucose tolerance could be centration stabilized and remained at the pretransplant achieved with a graft of sufficient size. However, it has level for several weeks in the severely diabetic group, been shown that even in rats transplanted intraportally indicating that at least some islets engrafted successwith a very large number of islets (3000), carbohydrate fully. Plasma glucose concentrations only progressively metabolism is not totally normalized (8), presumably beincreased in the untreated severely diabetic rats. These cause of the nonphysiological implantation site and the observations indicate that more extreme hyperglycemia resultant lower portal and higher peripheral circulating insulin levels.
was not responsible for the poorer function or impaired survival of islets transplanted into the severely diabetic results of islet transplantation are currently being reported when total parenteral nutrition (TPN) is used for animals.
While the beneficial effects of insulin administration 10-14 days posttransplantation. While the rationale for this is to avoid glucose toxicity during the engraftment on the insulin content or function of islets transplanted under the kidney capsule (1,14,23) and intraportally (18) period, the fact that TPN necessitates the IV infusion of large amounts of insulin could possibly also improve the have been attributed to more normal glucose levels and reduced glucose toxicity (1,14), they could equally re-survival or function of transplanted islets by exposing them to higher portal insulin levels. flect an effect of insulin per se. As well as its effects on glucose kinetics, insulin has several other distinct ac-
